List of insiders holdings for Inotiv Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Savanna Holdings LLC P2 Capital Partners LLC P2 Capital Master Fund I L.P. P2 Capital Fund IV L.P. MOLLER CLAUS J 10% Owner | 2022-09-20 09:01:30 | 8,125,178 127,516 | 8,252,694 | Form 4 |
| 2 | KISSINGER PETER KISSINGER CANDICE B 10% Owner | 2018-09-18 21:50:56 | 1,881,677 0 | 1,881,677 | Form 4 |
| 3 | Leasure Robert Jr. President and CEO | 2026-02-19 16:39:41 | 1,256,215 105,000 | 1,361,215 | Form 4 |
| 4 | BAKER ANDREW H Jermyn Street Associates LLC 10% Owner | 2024-04-03 10:47:10 | 1,260,024 0 | 1,260,024 | Form 13D |
| 5 | Costa Brava Partnership III LP Roark Rearden & Hamot LLC HAMOT SETH W 10% Owner | 2012-01-09 17:11:05 | 1,099,750 0 | 1,099,750 | Form 13D |
| 6 | Sagartz John E Chief Strategy Officer | 2026-02-19 16:40:25 | 735,697 0 | 735,697 | Form 4 |
| 7 | Sagartz Kimberly L 10% Owner | 2021-07-09 06:01:24 | 634,759 0 | 634,759 | Form 13G |
| 8 | SW Chrysalis LLC 10% Owner | 2019-04-24 20:34:02 | 632,475 0 | 632,475 | Form 13G |
| 9 | Cragg Scott Director | 2022-04-05 16:16:00 | 4,715 499,095 | 503,810 | Form 4 |
| 10 | Shepperd Richard M President & CEO | 2008-03-20 16:39:24 | 275,000 0 | 275,000 | Form 4 |
| 11 | Landman David Director | 2025-03-18 16:13:28 | 216,243 0 | 216,243 | Form 4 |
| 12 | Beattie John Gregory Chief Operating Officer | 2025-03-18 16:14:53 | 186,761 0 | 186,761 | Form 4 |
| 13 | Neff R Matthew Director | 2025-12-02 16:41:00 | 151,102 0 | 151,102 | Form 4 |
| 14 | Taylor Beth A. Chief Financial Officer | 2026-02-19 16:41:21 | 145,480 0 | 145,480 | Form 4 |
| 15 | Flynn Joseph Earl Chief Commercial Officer | 2021-05-11 16:32:36 | 128,394 0 | 128,394 | Form 4 |
| 16 | Brown Nigel Director | 2025-03-18 16:10:38 | 104,929 0 | 104,929 | Form 4 |
| 17 | EVANS DONNIE A Vice President Engineering | 2004-03-19 15:25:36 | 104,625 0 | 104,625 | Form 4 |
| 18 | Johnson Richard Allen Director | 2023-04-04 16:28:54 | 97,780 0 | 97,780 | Form 4 |
| 19 | SHOUP RONALD E Chief Scientific Officer | 2007-12-14 13:41:36 | 89,921 0 | 89,921 | Form 4 |
| 20 | Harrington Michael J Director | 2025-03-18 16:08:03 | 76,892 0 | 76,892 | Form 4 |
| 21 | Coelho Mary Theresa Director | 2025-04-02 16:32:56 | 74,303 0 | 74,303 | Form 4 |
| 22 | Pitchford William D Chief Human Resources Officer | 2022-12-29 07:12:01 | 74,051 0 | 74,051 | Form 4 |
| 23 | Lemke Jacqueline M President and CEO | 2016-03-02 17:04:03 | 60,685 9,000 | 69,685 | Form 4 |
| 24 | Davis Gregory Cole Director | 2023-04-04 16:28:38 | 67,780 0 | 67,780 | Form 4 |
| 25 | Hardy Adrian Chief Commercial Officer | 2025-03-18 16:15:20 | 58,420 0 | 58,420 | Form 4 |
| 26 | Oakley Daniel Thomas Chief Operating Officer | 2019-12-04 16:57:02 | 57,520 0 | 57,520 | Form 4 |
| 27 | Krupp Jeffrey Arthur Chief Human Resources Officer | 2025-03-18 16:06:54 | 53,557 0 | 53,557 | Form 4 |
| 28 | Freeman Jeffrey Brennan VP-Finance & Corp. Controller | 2025-03-18 16:14:28 | 42,478 0 | 42,478 | Form 4 |
| 29 | Downing Philip A Sr. VP, Preclinical Srvcs. | 2022-02-23 17:22:46 | 42,195 0 | 42,195 | Form 4 |
| 30 | Harkness James Chief Operating Officer, RMS | 2022-03-16 10:47:25 | 38,968 0 | 38,968 | Form 4 |
| 31 | Landis John B. Director | 2012-08-20 18:03:27 | 30,000 0 | 30,000 | Form 4 |
| 32 | CHAIT EDWARD Chief Business Officer | 2007-11-08 14:52:59 | 30,000 0 | 30,000 | Form 4 |
| 33 | Hidalgo Alberto F Jr VP, Bus. Development & Mrkting | 2010-08-19 16:29:27 | 30,000 0 | 30,000 | Form 4 |
| 34 | BREWER JON VP Sales/Marketing | 2008-10-02 16:58:40 | 30,000 0 | 30,000 | Form 4 |
| 35 | SILVON MICHAEL P Vice President | 2004-03-02 15:59:07 | 30,000 0 | 30,000 | Form 4 |
| 36 | Garrett Michael Chief Commercial Officer | 2023-12-15 17:33:47 | 26,467 0 | 26,467 | Form 4 |
| 37 | Chilton Anthony S CEO and President | 2012-04-11 16:04:46 | 25,000 0 | 25,000 | Form 4 |
| 38 | HENNINGSEN GERRY Director BAS Evansville | 2004-03-02 15:48:51 | 20,000 0 | 20,000 | Form 4 |
| 39 | COX MICHAEL R VP Finance & Administration | 2010-04-19 18:12:17 | 20,000 0 | 20,000 | Form 4 |
| 40 | Hodges Kathleen Vice President of Quality | 2010-04-19 18:17:10 | 20,000 0 | 20,000 | Form 4 |
| 41 | NOONE MICHAEL S Dir. of Clinical Affairs, Balt | 2004-03-02 15:47:18 | 20,000 0 | 20,000 | Form 4 |
| 42 | OMACHINSKI DAVID L Director | 2012-08-20 18:00:56 | 20,000 0 | 20,000 | Form 4 |
| 43 | REEVES-KERNER LINA L V.P. Human Resources | 2010-04-19 18:11:26 | 20,000 0 | 20,000 | Form 4 |
| 44 | BRUNTLETT CRAIG S Senior V P, Sales Development | 2010-04-19 18:10:51 | 20,000 0 | 20,000 | Form 4 |
| 45 | DANIELS LESLIE B Director | 2010-08-18 16:31:22 | 15,000 0 | 15,000 | Form 4 |
| 46 | Boulet Larry Steven Director | 2012-08-20 18:02:02 | 15,000 0 | 15,000 | Form 4 |
| 47 | Baim Michael VP Bioanalytical Services | 2020-12-04 16:07:41 | 14,656 0 | 14,656 | Form 4 |
| 48 | BAITINGER WILLIAM E Director | 2008-09-08 16:18:46 | 12,000 0 | 12,000 | Form 4 |
| 49 | CRABB DAVID W Director | 2012-08-20 18:04:13 | 11,300 0 | 11,300 | Form 4 |
| 50 | Sullivan A. Charlene Director | 2012-08-20 18:06:31 | 10,000 0 | 10,000 | Form 4 |
| 51 | Castetter Andrea EVP, General Counsel & Sec'y | 2026-01-16 16:07:23 | 10,000 0 | 10,000 | Form 4 |
| 52 | Potrzebowski Jeffrey VP, Finance & CFO | 2014-06-10 16:40:53 | 10,000 0 | 10,000 | Form 4 |
| 53 | SAWYERS WILLIAM Laboratory Director Director | 2004-03-02 15:54:19 | 10,000 0 | 10,000 | Form 4 |
| 54 | MCCLURE MARGARET B Dir, Pharmaceutical Lab. Div. | 2004-03-02 15:50:27 | 10,000 0 | 10,000 | Form 4 |
| 55 | Perrow Wendy Director | 2019-09-11 16:18:20 | 10,000 0 | 10,000 | Form 4 |
| 56 | Dougherty Connie Leigh VP, Business Development | 2016-05-27 16:05:51 | 9,074 0 | 9,074 | Form 4 |
| 57 | Blumhoff Jill VP, Finance & CFO | 2019-12-04 16:57:19 | 8,811 0 | 8,811 | Form 4 |
| 58 | Beraldi Fernanda Former Gen'l Counsel & Sec'y | 2024-01-10 17:19:15 | 7,840 0 | 7,840 | Form 4 |
| 59 | Devine John P VP--Toxicology | 2014-08-26 16:17:56 | 5,000 0 | 5,000 | Form 4 |
| 60 | Payne Lori VP-Bioanalytical Services | 2013-01-17 16:10:50 | 500 0 | 500 | Form 4 |
| 61 | Rohde-Johnson Candace A Director, Instruments Director | 2013-05-17 16:53:08 | 500 0 | 500 | Form 3 |
| 62 | Cordova Emilio V.P. of Business Development | 2007-11-28 11:43:20 | 34 100 | 134 | Form 4 |
| 63 | DOSTER GARYL W Director | 2004-08-20 17:22:30 | 0 0 | 0 | Form 3 |
| 64 | Merrill R. Osheroff Director | 2014-01-30 16:01:19 | 0 0 | 0 | Form 3 |
| 65 | Bourdage James Sevall VP, Bioanalytical Services | 2014-06-19 16:16:13 | 0 0 | 0 | Form 3/A |
| 66 | Bibi Mark L General Counsel and Secretary | 2022-03-01 16:33:04 | 0 0 | 0 | Form 4 |